These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 8682089)
21. Predictors of outcome in patients with suspected myocarditis. Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053 [TBL] [Abstract][Full Text] [Related]
22. Outcome predictors in dilated cardiomyopathy or myocarditis. Kuethe F; Franz M; Jung C; Porrmann C; Reinbothe F; Schlattmann P; Egerer R; Mall G Eur J Clin Invest; 2017 Jul; 47(7):513-523. PubMed ID: 28556177 [TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Maisch B; Herzum M; Hufnagel G; Bethge C; Schönian U Eur Heart J; 1995 Dec; 16 Suppl O():153-61. PubMed ID: 8682087 [TBL] [Abstract][Full Text] [Related]
24. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods. Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331 [TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Frustaci A; Chimenti C; Calabrese F; Pieroni M; Thiene G; Maseri A Circulation; 2003 Feb; 107(6):857-63. PubMed ID: 12591756 [TBL] [Abstract][Full Text] [Related]
26. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. Dec GW; Palacios IF; Fallon JT; Aretz HT; Mills J; Lee DC; Johnson RA N Engl J Med; 1985 Apr; 312(14):885-90. PubMed ID: 3974674 [TBL] [Abstract][Full Text] [Related]
27. [Immunosuppressive therapy in myocarditis and dilated cardiomyopathy--a critical analysis]. Schultheiss HP Z Kardiol; 1989 Jun; 78(6):349-59. PubMed ID: 2667264 [TBL] [Abstract][Full Text] [Related]
28. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Camargo PR; Snitcowsky R; da Luz PL; Mazzieri R; Higuchi ML; Rati M; Stolf N; Ebaid M; Pileggi F Pediatr Cardiol; 1995; 16(2):61-8. PubMed ID: 7784236 [TBL] [Abstract][Full Text] [Related]
29. [Reversible dilated cardiomyopathy in a patient with acute, advanced heart failure and intense endothelial inflammatory reaction in endomyocardial biopsy--a case report]. Tyczyński P; Bilińska ZT; Dzielińska Z; Cedro K; Grzybowski J; Walczak E; Michalak E; Wagner T; Ruzyłło W Kardiol Pol; 2006 Oct; 64(10):1118-20. PubMed ID: 17089245 [TBL] [Abstract][Full Text] [Related]
30. Dilated cardiomyopathy and myocarditis in Kenya: an endomyocardial biopsy study. Sanderson JE; Olsen EG; Gatei D Int J Cardiol; 1993 Sep; 41(2):157-63. PubMed ID: 8282440 [TBL] [Abstract][Full Text] [Related]
31. Expression of MHC-I and MHC-II antigens in endomyocardial biopsies from patients with viral myocarditis and cardiomyopathy. Li W; Yu S; Zhao H Chin Med J (Engl); 1995 Nov; 108(11):809-11. PubMed ID: 8585971 [TBL] [Abstract][Full Text] [Related]
32. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease. Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212 [TBL] [Abstract][Full Text] [Related]
33. [Endomyocardial biopsy in children and adolescents]. Ruzyłło W; Bilińska ZT; Gajewski W Kardiol Pol; 1989; 32(2):87-96. PubMed ID: 2615140 [TBL] [Abstract][Full Text] [Related]
34. Detection of viral and bacterial protein in endomyocardial biopsies of patients with inflammatory heart muscle disease? Davydova J; Pankuweit S; Crombach M; Eckhardt H; Strache D; Faulhammer P; Maisch B Herz; 2000 May; 25(3):233-9. PubMed ID: 10904844 [TBL] [Abstract][Full Text] [Related]
35. Phenotype analysis of mononuclear cells in endomyocardial biopsy specimens from patients with viral myocarditis and dilated cardiomyopathy. Li W; Yu S; Wang DW J Tongji Med Univ; 1994; 14(4):213-5. PubMed ID: 7760430 [TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive therapy of biopsy proved immune-mediated lymphocytic myocarditis in the virus-negative and virus-positive patients. Blagova O; Nedostup A; Kogan E; Zaitsev A; Fomin V Cardiovasc Pathol; 2020; 49():107260. PubMed ID: 32683240 [TBL] [Abstract][Full Text] [Related]
38. Overview on chronic viral cardiomyopathy/chronic myocarditis. Schultheiss HP; Kühl U Ernst Schering Res Found Workshop; 2006; (55):3-18. PubMed ID: 16329654 [TBL] [Abstract][Full Text] [Related]
39. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. Lauer B; Schannwell M; Kühl U; Strauer BE; Schultheiss HP J Am Coll Cardiol; 2000 Jan; 35(1):11-8. PubMed ID: 10636253 [TBL] [Abstract][Full Text] [Related]